Oncoscope Inc — Form D/A
Oncoscope Inc of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2011-07-21. The offering totals $2.0M, of which $891K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-07-21
- Form: D/A
- Accession: 0001420865-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $891K
- Remaining: $1.1M
- Investors: 34
- Date of first sale: 2011-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-158779
Issuer
- Name: Oncoscope Inc
- CIK: 0001420865
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 318 BLACKWELL STREET, SUITE 240, DURHAM, NC, 27701
- Phone: 919-251-8030
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Lister A Delgado | Director | Durham, NC |
| Adam A Wax | Director | Durham, NC |
| Matthew A Megaro | Director | Durham, NC |
| James A Dougherty | Director | New York, NY |
| Paul A Priu | Director | Raleigh, NC |
| Perry A Genova | Director | Durham, NC |
| Perry A Genova | Executive Officer | Durham, NC |
| John A Autrey | Executive Officer | Durham, NC |
| Daniel A Pelak | Director | Durham, NC |
Other filings by this issuer (4)
More